市场调查报告书
商品编码
1499570
高流量人工呼吸器市场:按模式、类型和最终用户划分 - 全球预测 2024-2030High Flow Ventilators Market by Modality (Portable High Flow Ventilators, Trolley Mounted High Flow Ventilators), Type (Adult Ventilator, Infant or Neonatal Ventilator, Pediatric Ventilator), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
高流量人工呼吸器市场规模预计2023年为15.1亿美元,2024年达到16.1亿美元,预计2030年将达到23.7亿美元,复合年增长率为6.61%。
高流量人工呼吸器市场包括高流量呼吸器的开发、生产和销售,高流量人工呼吸器是用于为无法充分呼吸的患者提供呼吸支援的医疗设备。这些人工呼吸器旨在将高气流以及加湿和温暖直接输送到患者的气道中。呼吸系统疾病盛行率和发病率的上升、手术数量的增加以及重症加护中对具有成本效益的高端技术的需求不断增加正在推动市场成长。高流量人工呼吸器的高成本、操作挑战、操作设备需要专门培训以及人工呼吸器相关肺损伤的潜在风险是限制市场开拓的因素。高流量人工呼吸器中先进技术的整合预计将在高流量人工呼吸器市场创造商机。加强对医疗基础设施的投资也为高流量人工呼吸器市场提供了成长潜力。
主要市场统计 | |
---|---|
基准年[2023] | 15.1亿美元 |
预测年份 [2024] | 16.1亿美元 |
预测年份 [2030] | 23.7亿美元 |
复合年增长率(%) | 6.61% |
区域洞察
由于先进的医疗基础设施、不断增加的医疗支出以及呼吸系统疾病的高发病率,美洲尤其是北美的高流量人工呼吸器市场正在强劲增长。此外,该地区较早采用创新技术也有助于增强市场活力。由于强大的研发活动和积极的政府倡议,美国市场正在经历显着成长。受医疗成本上升、人口成长(尤其是更容易患呼吸道疾病的老年人)以及医疗设施改善的推动,南美洲的高流量人工呼吸器市场正在稳步增长。由于经济成长、医疗保健成本上升和老年人口不断增加,亚太地区正在成为一个快速扩张的高流量人工呼吸器市场。由于中国和印度人口众多、慢性呼吸道疾病盛行率上升以及医疗基础设施不断改善,高流量人工呼吸器市场正在扩大。该地区也受惠于政府加强卫生系统和提高患者对先进呼吸护理设备认识的努力。欧洲的特点是医疗保健系统完善、呼吸道疾病盛行率高以及确保高品质标准的严格卫生法规,因此需求量很大。由于医疗基础设施投资增加和呼吸健康意识增强,中东地区正在经历成长。与此同时,由于获得医疗设施的机会有限和医疗支出下降,非洲的成长已经放缓。然而,由于医疗保健系统的改善和先进医疗设备的逐步引进,一些非洲市场存在成长潜力。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在高流量人工呼吸器市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对高流量人工呼吸器市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对当前高流量人工呼吸器市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[182 Pages Report] The High Flow Ventilators Market size was estimated at USD 1.51 billion in 2023 and expected to reach USD 1.61 billion in 2024, at a CAGR 6.61% to reach USD 2.37 billion by 2030.
The high flow ventilators market comprises the development, production, and sale of high flow ventilators, which are medical devices used to provide respiratory support to patients who cannot breathe adequately. These ventilators are designed to deliver a high airflow rate, along with humidification and heating, directly to the patient's airways. The rising prevalence and incidence of respiratory disorders, the growing number of surgeries, and the increasing need for cost-effective and high-end technologies in critical care are driving the market growth. High costs of high-flow ventilators with operational challenges, requiring specialized training for device operation, and potential risks of ventilator-associated lung injuries limit market development. Integration of advanced technologies in high-flow ventilators is expected to create opportunities in the high-flow ventilators market. In addition, investments to enhance the healthcare infrastructure also provide potential for growth of the high flow ventilators market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.51 billion |
Estimated Year [2024] | USD 1.61 billion |
Forecast Year [2030] | USD 2.37 billion |
CAGR (%) | 6.61% |
Regional Insights
In the Americas, particularly in North America, the high flow ventilators market is witnessing robust growth, due to the advanced healthcare infrastructure, increased healthcare spending, and a high prevalence of respiratory diseases. Additionally, the region's quick adoption of innovative technologies contributes to the market's dynamism. The United States is witnessing significant growth in the market, driven by strong research and development activities and favorable government initiatives. South America's market for high flow ventilators is growing steadily, propelled by increasing healthcare expenditure, a growing population, especially the elderly more prone to respiratory conditions, and improving healthcare facilities. Asia-Pacific is emerging as a rapidly expanding market for high flow ventilators, driven by economic growth, increasing healthcare expenditures, and a rising geriatric population. China and India observe an evolving high-flow ventilator market due to their large population base, increasing incidence of chronic respiratory diseases, and ongoing improvement in healthcare infrastructure. The region also benefits from government initiatives to enhance healthcare systems and increase patient awareness about advanced respiratory care devices. Europe is marked by high need driven by well-established healthcare systems, a high prevalence of respiratory diseases, and rigorous health regulations ensuring high-quality standards. The Middle East is witnessing growth due to advancing investments in healthcare infrastructure and rising awareness about respiratory health. Africa, however, experiences slower growth, hindered by limited access to healthcare facilities and lower healthcare spending. Nevertheless, initiatives to improve healthcare systems and the slowly increasing adoption of advanced medical devices offer potential for growth in select African markets.
Market Insights
The market dynamics represent an ever-changing landscape of the High Flow Ventilators Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the High Flow Ventilators Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the High Flow Ventilators Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Inspiration Healthcare Launches New Specialist Neonatal Ventilator
Inspiration Healthcare has unveiled the SLE1500, an addition to its neonatal ventilator offerings. This state-of-the-art compact respiratory support system is engineered to cater to the delicate needs of neonates requiring respiratory assistance by introducing six versatile non-invasive ventilation modes, including flow and pressure-controlled nasal Continuous Positive Airway Pressure (nCPAP), high-flow oxygen therapy, and manual flow for bubble CPAP. These are enhanced by integrating Pulse Oximetry (SpO2) and the revolutionary automatic oxygen control (auto FiO2) facilitated by OxyGenie, Inspiration Healthcare's proprietary oxygen-controlling algorithm. [Published On: 2023-11-08]
Telesair Receives USD 22 Million Backing for Home Respiratory Solution
Telesair Inc., secured USD 22 million in Series A financing to enhance its innovative high flow oxygen therapy solutions for both the ICU and homecare settings. This significant financial backing, led by Pasaca Capital and Honeywell, along with contributions from distinguished investors like ZhenCheng Capital, Shangbay Capital, Device of Tomorrow Capital, Berkeley Catalyst Fund, and Ultrastar Ventures LLC, aims to propel the commercial launch of Telesair's Bonhawa Respiratory Humidifier. Moreover, the investment is expected to accelerate the development of a second-generation product tailored to improve patient transitions from hospital to home, emphasizing safety and prolonged care at home. [Published On: 2023-01-21]
Getinge Expands the ICU Offering with the New Ventilator Servo-c
Getinge introduced its latest innovation, the Servo-c mechanical ventilator, to specific global markets. This cutting-edge device encapsulates years of expertise and provides lung-protective therapy for adult and pediatric patients to offer comprehensive care. Its launch represents Getinge's commitment to enhancing healthcare by making advanced ventilatory support accessible and economically feasible for a broader range of hospitals worldwide. This strategic move underlines the company's dedication to improving patient outcomes and supporting healthcare facilities in delivering top-tier medical care. [Published On: 2023-01-18]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the High Flow Ventilators Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the High Flow Ventilators Market, highlighting leading vendors and their innovative profiles. These include AIR LIQUIDE MEDICAL SYSTEMS SA, Armstrong Medical Ltd., Biosys Biyomedikal Muhendislik A.S., BMC Medical Co., Ltd., Delta A Healthcare, Dragerwerk AG & Co. KGaA, Essex Industries, Inc., GE HealthCare Technologies Inc., Getinge AB, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hamilton Medical AG, HERSILL, S.L., Inspiration Healthcare Group PLC, Koninklijke Philips N.V., Medtronic PLC, MEK-ICS Co., Ltd, Movair, Nihon Kohden OrangeMed, Inc., ResMed Corp., Shenyang RMS Medical Tech Co., Ltd, Shenzhen Comen Medical Instruments Co., Ltd., Techme Corporation, UTAS Co., VYAIRE MEDICAL, INC., and ZOLL Medical Corporation by Asahi Kasei Corporation.
Market Segmentation & Coverage